U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06906861) titled 'Epistaxis in Patients Receiving Oral Anticoagulants and Antiplatelet: Prevalence Risk Factors At a Tertiary Care Hospital in Nepal' on March 26.
Brief Summary: This study aims to determine the prevalence of epistaxis and identify the associated risk factors among patients receiving oral anticoagulants and antiplatelet at a tertiary care hospital in Nepal.
A cross-sectional study was conducted among 284 patients receiving oral anticoagulants at a tertiary care hospital over a one-year period. Data were collected through structured interviews and medical record reviews. The prevalence of epistaxis with corresponding 95% CI was calcul...